Results 181 to 190 of about 358,784 (300)

Multiomic spatial atlas shows deleted in malignant brain tumors 1 (DMBT1) glycoprotein is lost in colonic dysplasia

The Journal of Pathology, Volume 266, Issue 1, Page 51-65, May 2025.
Abstract Colorectal cancer (CRC) is responsible for over 900,000 annual deaths worldwide. Emerging evidence supports pro‐carcinogenic bacteria in the colonic microbiome are at least promotional in CRC development and may be causal. We previously showed toxigenic C.
Emily H Green, Subhag R Kotrannavar, Megan E Rutherford, Hannah M Lunnemann, Harsimran Kaur, Cody N Heiser, Hua Ding, Alan J Simmons, Xiao Liu, D Borden Lacy, M Kay Washington, Martha J Shrubsole, Qi Liu, Ken S Lau, Cynthia L Sears, Robert J Coffey, Julia L Drewes, Nicholas O Markham   +17 more
wiley   +1 more source

Mucinous rectal adenocarcinoma recurrence: A case report and literature review. [PDF]

Radiol Case Rep
Sood R, Badjatia T, Bhargava P.
europepmc   +1 more source

Cellular origins of mucinous ovarian carcinoma

The Journal of Pathology, Volume 266, Issue 1, Page 9-25, May 2025.
Abstract Mucinous ovarian carcinoma (MOC) is a rare histotype of epithelial ovarian cancer. Its origins are obscure: while many mucinous tumours in the ovary are metastases from the gastrointestinal tract, MOC can occur as an ovarian primary; however, the cell of origin is not well established.
Nicola S Meagher, Martin Köbel, Anthony N Karnezis, Aline Talhouk, Michael S Anglesio, Andrew Berchuck, Simon A Gayther, Paul PD Pharoah, Penelope M Webb, Susan J Ramus, Kylie L Gorringe   +10 more
wiley   +1 more source

Microsecretory adenocarcinoma: simplifying the diagnosis of a recently recognized salivary gland and cutaneous adnexal neoplasm. [PDF]

Diagn Pathol
Abdelmoneim NA, Elfouly AM, Abou Madawi NA.   +2 more
europepmc   +1 more source

Risk factors for lymph ascites after surgery for endometrial cancer and impact on lymphedema of the legs. A prospective longitudinal Swedish multicenter study

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 5, Page 976-987, May 2025.
Lymph ascites was present in one third of women 4–6 weeks after surgery for endometrial cancer, although mostly in low volume. Minimally invasive surgery appeared to be a risk‐reducing factor of lymph ascites. Presence of lymph ascites 4–6 weeks after surgery seemed to predict lymphedema within 1 year.
Madelene Wedin, Karin Glimskär Stålberg, Ulrika Ottander, Åsa Åkesson, Gabriel Lindahl, Ninnie Borendal Wodlin, Preben Kjølhede   +6 more
wiley   +1 more source

Comprehensive Overview of Molecular, Imaging, and Therapeutic Challenges in Rectal Mucinous Adenocarcinoma. [PDF]

Int J Mol Sci
Berar M, Ciocan A, Moiș E, Furcea L, Popa C, Ciocan RA, Zaharie F, Puia C, Al Hajjar N, Caraiani C, Rusu I, Graur F.   +11 more
europepmc   +1 more source

Papillary and ductal patterns of mesonephric‐like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas

Histopathology, Volume 86, Issue 6, Page 862-877, May 2025.
Mesonephric‐like adenocarcinomas can be misclassified as other Müllerian carcinomas. Papillary (A, B), mixed papillary/ductal (C) or ductal (D) patterns can be overlooked. Aims Mesonephric‐like adenocarcinoma (MLA) of the endometrium is often a diagnostic challenge, due to its morphological resemblance to other more common Müllerian neoplasms.
Ardalan Akbari, Jennifer Pors, Amy Lum, Samuel Leung, Dawn Cochrane, Amy Jamieson, Jessica McAlpine, Stefan Kommoss, Jutta Huvila, David Huntsman, Aline Talhouk, Naveena Singh, C Blake Gilks, Lynn Hoang   +13 more
wiley   +1 more source

Claudin 18.2 Is Not a Promising Biomarker for Targeted Immunotherapy in Prostatic Cancers. [PDF]

In Vivo
Baek J, Shim YR, Gu MJ.
europepmc   +1 more source

KRAS and NKX2‐1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung

Journal of Thoracic Oncology, 2016
D. Hwang, L. Sholl, V. Rojas-Rudilla, Dimity L Hall, Priyanka Shivdasani, E. Garcia, L. Macconaill, M. Vivero, J. Hornick, F. Kuo, N. Lindeman, Fei Dong   +11 more
semanticscholar   +1 more source

Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8+ T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1

Advanced Science, Volume 12, Issue 13, April 3, 2025.
T‐cell immunotherapy eliminates cancer growth by activating T cells, but immunosuppressive factors hinders their effectiveness, resulting in treatment failure. Here, ribonuclease 1 (RNase1) causes T‐cell dysfunction and promotes exhausted T‐cell signatures in cancers.
Wen‐Hao Yang, Bao‐Yue Huang, Hsing‐Yu Rao, Peng Ye, Bi Chen, Hao‐Ching Wang, Chih‐Hung Chung, Heng‐Hsiung Wu, Hung‐Rong Yen, Shao‐Chun Wang, Jong‐Ho Cha, Xiuwen Yan, Muh‐Hwa Yang, Mien‐Chie Hung   +13 more
wiley   +1 more source